For the first time, scientists are able to directly compare the different kinds of injury that mechanical ventilation causes to cells in the lungs.

In a new study, using a ventilator-on-a-chip model developed at The Ohio State University, researchers found that shear stress from the collapse and reopening of the air sacs is the most injurious type of damage.

This miniature “organ-on-a-chip” model simulates not only lung injury during mechanical ventilation, but also repair and recovery, in human-derived cells in real time, said co-lead author Samir Ghadiali, PhD, professor and chair of biomedical engineering at Ohio State.

“The initial damage is purely physical, but the processes after that are biological in nature — and what we’re doing with this device is coupling the two,” Ghadiali said.

The team hopes the device will also help in the hunt for therapies to address ventilator-induced lung injury.

“This is an important advance in the field that will hopefully allow for a better understanding of how lung injury develops in mechanically ventilated patients and identification of therapeutic targets so that we can give drugs to prevent that kind of injury or treat it when it happens,” said co-lead author Joshua Englert, MD, associate professor of pulmonary, critical care and sleep medicine at The Ohio State University Wexner Medical Center.

The research was published recently in the journal Lab on a Chip.

Ventilators save the lives of patients with severe respiratory problems related to disease or trauma, but it has been known for a long time that the mechanical forces exerted on the lungs also cause injury. The damage at the cellular level can make the barrier between tiny air sacs and capillaries carrying blood become leaky, leading to fluid buildup that interferes with oxygen getting to the lungs.

Of particular value is the ventilator-on-a chip’s measurement of real-time changes to cells that affect the integrity of that barrier, enabled by an innovative approach: growing human lung cells on a synthetic nanofiber membrane mimicking the complex lung matrix. It’s closer to the authentic ventilated lung microenvironment than any similar lung chip systems to date, the researchers say.

The device measures the effects of three types of mechanical stress on the integrity of the barrier: lung cell stretch from overinflation, increased pressure on lung cells, and cyclical collapse and reopening of air sacs.

Experiments showed that overinflation with a high volume of air and cyclic collapse and reopening of air sacs both led the barrier to become leaky, but the cells could recover more quickly from overinflation than from the repetitive opening and closing of air sacs.

Englert said the collapse and reopening may be more problematic because it makes fluid in the lungs move, exposing cells to high amounts of shear stress.

“There really hasn’t been a lot of data that could allow for the comparison of those two injurious forces in the same system,” he said. “But now for the first time, we can use the same device with the same cells and induce both types of injury and see what happens. Our data suggests neither one of them is good, they’re both injurious, but that the collapse and reopening seems to be more severe and makes recovery harder.”

This finding was a demonstration of the model’s sophistication, Ghadiali said.

“We knew for a long time that collapse and reopening is a pretty injurious force, but we never could measure it in real time,” he said. “Now that we know that collapse and reopening injury happens much quicker and takes a long time to recover, we plan to use the ventilator on a chip to figure out how to prevent this injury and/or enhance the repair.”

Next steps involve modeling diseases such as pneumonia and traumatic injuries experienced by ICU patients in combination with mechanical action.

“We’re in the early stages of developing some of those models, diving a little bit deeper into the complexity of lung injury in ICU patients,” Englert said. “This model is a platform we can build upon.”

Ghadiali and Englert, also investigators in Ohio State’s Davis Heart and Lung Research Institute, credited first author Basia Gabela-Zuniga, who recently received her PhD in biomedical engineering, with getting the project over the finish line, and acknowledged the contributions of College of Engineering co-authors Heather Powell and Natalia Higuita-Castro. Additional co-authors were Vasudha Shukla and Christopher Bobba of Ohio State.

This work was supported by the National Institutes of Health and the U.S. Department of Defense.



Source link

Leave a Reply

Your email address will not be published. Required fields are marked *

Before you post, please prove you are sentient.

What is melted ice?

Explore More

Study may bring improved therapy to preselected lung cancer patients

Nonsmokers who develop lung cancer can be treated effectively with new drugs, but their tumors refuse to surrender without a fight. The drugs stop working in the long term because

Antifungal drug improves key cystic fibrosis biomarkers in clinical study

A drug widely used to treat fungal infections improved key biomarkers in lung tissue cultures as well as in the noses of patients with cystic fibrosis, a clinical study by

Genetic code change drives common lung cancer type

A team led by researchers at NYU Langone Health’s Perlmutter Cancer Center has identified a gene that drives development of the second most common type of lung carcinoma, offering greater